Literature DB >> 30811016

Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model.

Wayne Monsky1, Christina Keravnou2, Michalakis Averkiou2.   

Abstract

PURPOSE: To obtain a complete response with thermal ablation, the margin and entire tumor volume must be treated. Real-time ultrasound visualization is limited during ablation due to gas production. This study assesses the feasibility of fusing volumetric contrast-enhanced ultrasound (CEUS), obtained immediately prior to microwave ablation, with real-time CEUS during and following ablation in a machine-perfused porcine liver.
METHODS: Ten, 3-4 cm microwave ablations were performed in five explanted perfused livers. Prior to ablation, microbubbles were injected into the vasculature while an ultrasound sweep across the liver captured a volumetric image during maximum enhancement. This volumetric image was then fused to overlay the real-time ultrasound imaging. Since the perfused livers did not have tumors, a spherical marker circumscribing a target volume was placed on the images. Approximatively, 75% of the total intended circumscribed spherical volume was ablated. Following ablation, a second bolus injection of ultrasound contrast was administered demonstrating continued enhancement of the intentionally non-ablated 25%. A second volumetric image of the post-ablation CEUS was then fused to overlay the real-time ultrasound images for guidance during ablation of the remaining enhancing volume.
RESULTS: Technical success was achieved in 100% of the cases. The pre- and then the post-ablation CEUS volume was fused with real-time imaging during antenna placement for initial and subsequent ablation.
CONCLUSION: CEUS-CEUS fusion during thermal ablation is feasible and greatly improves the workflow. The approach may augment the use of dynamic CEUS for guidance, improving antenna placement, and aiding in the identification and ablation of initial and residual enhancing tissue.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Image fusion; Microwave ablation

Mesh:

Substances:

Year:  2019        PMID: 30811016      PMCID: PMC6704228          DOI: 10.1007/s40477-019-00366-5

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  38 in total

1.  Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.

Authors:  Kazue Shiozawa; Manabu Watanabe; Ryuji Takayama; Masayoshi Takahashi; Noritaka Wakui; Kazunari Iida; Yasukiyo Sumino
Journal:  J Clin Ultrasound       Date:  2010-05       Impact factor: 0.910

2.  Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.

Authors:  Yasunori Minami; Masatoshi Kudo; Hobyung Chung; Toshihiko Kawasaki; Yukinobu Yagyu; Taro Shimono; Hitoshi Shiozaki
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

3.  Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.

Authors:  Yoshiyasu Kisaka; Masasi Hirooka; Teru Kumagi; Takahide Uehara; Yoichi Hiasa; Seishi Kumano; Hiroaki Tanaka; Kojiro Michitaka; Norio Horiike; Teruhito Mochizuki; Morikazu Onji
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

4.  Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.

Authors:  Debra A Gervais; S Nahum Goldberg; Daniel B Brown; Michael C Soulen; Steven F Millward; Dheeraj K Rajan
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

Review 5.  Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

6.  Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations.

Authors:  G D Dodd; M S Frank; M Aribandi; S Chopra; K N Chintapalli
Journal:  AJR Am J Roentgenol       Date:  2001-10       Impact factor: 3.959

7.  Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors.

Authors:  Edward Leen; Senthil Kumar; Shahid A Khan; Gavin Low; Keh Oon Ong; Paul Tait; Mike Averkiou
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 8.  Design and endpoints of clinical trials in hepatocellular carcinoma.

Authors:  Josep M Llovet; Adrian M Di Bisceglie; Jordi Bruix; Barnett S Kramer; Riccardo Lencioni; Andrew X Zhu; Morris Sherman; Myron Schwartz; Michael Lotze; Jayant Talwalkar; Gregory J Gores
Journal:  J Natl Cancer Inst       Date:  2008-05-13       Impact factor: 13.506

9.  Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.

Authors:  Dongil Choi; Hyo K Lim; Won Jae Lee; Seung Hoon Kim; Young Han Kim; Seong Hyun Kim; Jae Hoon Lim
Journal:  J Ultrasound Med       Date:  2003-11       Impact factor: 2.153

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  2 in total

Review 1.  Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography.

Authors:  Agostino Inzerillo; Maria Franca Meloni; Adele Taibbi; Tommaso Vincenzo Bartolotta
Journal:  World J Hepatol       Date:  2022-04-07

Review 2.  Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies.

Authors:  John R Eisenbrey; Helena Gabriel; Esika Savsani; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.